Skip to content

Erasca, Inc. ERAS Free cash flow yield

Free cash flow yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
9.6%-0.9pp
Eli Lilly logo
Eli LillyLLY
1.4%+0.9pp
Pfizer logo
PfizerPFE
7.8%+4.6pp
Amgen logo
AmgenAMGN
4.5%-2.0pp
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-5.6%-1.6pp
Tango Therapeutics logo
Tango TherapeuticsTNGX
-4.8%-2.3pp

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.25B+1,196%
Enterprise value$4.25B+1,265%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Calculated from Erasca, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s free cash flow yield?
Erasca, Inc. (ERAS) reported free cash flow yield of -1.8% in Q1 2026.
How has Erasca, Inc.'s free cash flow yield changed year-over-year?
Erasca, Inc.'s free cash flow yield increased by 93.5% year-over-year, from -27.8% to -1.8%.
What is the long-term trend for Erasca, Inc.'s free cash flow yield?
Over 4 years (2021 to 2025), Erasca, Inc.'s free cash flow yield has grown at a 30.8% compound annual growth rate (CAGR), from -3.1% to -9.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.